Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

CHINA: A Pill that Treats and Tells




 

Reuters (08.27.12)

Sensors small enough to be placed in patients’ medications are being tested as a means to provide digital feedback about patient adherence to drug-taking regimens. This new technology will be pilot tested in China for treating TB. About the size of a salt grain, the sensor is activated when it gets wet from stomach juices, completing a circuit that generates a tiny voltage. The sensor has no battery or antenna. Digital data from the sensor, recorded by a skin patch worn on the torso, can be sent to a phone or computer. The data can then be viewed on a computer network by patients, caregivers, and physicians. The technology, devised by Redwood City, Calif.-based Proteus Digital Health Inc., was approved last month by the Food and Drug Administration. “Overall, people only take their medications half of the time ... adherence is a really big issue across all treatments,” said Eric Topol, chief academic officer of Scripps Health, a nonprofit medical service provider. Proteus has partnered with the Bill & Melinda Gates Foundation and China’s Center for Disease Control to test the technology for TB treatment. With the help of a $560,000 Gates Foundation grant, Proteus will test the sensors in Chinese TB patients. Treatment for TB can have unpleasant side effects, leading some patients to drop out of treatment and place others at risk. Health experts question whether patients will accept the monitoring system. “People may not want to wear the patch and have the medications because they might feel like big brother is watching,” Topol conceded. “The point of this technology is not to say you are being a bad patient. The point is to have accurate data,” said George Savage, Proteus’ chief medical officer and co-founder.



 


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in August 28, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.